J-shaped association between serum uric acid and acute coronary syndrome in patients with essential hypertension

Postgrad Med J. 2020 Feb;96(1132):73-78. doi: 10.1136/postgradmedj-2019-136650. Epub 2019 Sep 5.

Abstract

Background: The prognostic value of serum uric acid (SUA) for incident acute coronary syndrome (ACS) in hypertensive subjects is uncertain. Therefore, the present study examined the association between SUA and incident ACS in a large cohort of Chinese hypertensive adults.

Methods: This was a retrospective cohort study, which enrolled 5473 Chinese community-dwelling hypertensive patients from 1 January 2012 to 31 December 2012. Study outcomes were ACS events, and patients were followed until 31 December 2016. Cox regression analyses were conducted to determine adjusted HRs and 95% CIs for baseline SUA tertiles (low, middle and high group) and for men and women separately.

Results: A total of 5473 participants were included in the analysis (median follow-up was 4.5 years). Participants were divided into tertiles based on SUA levels. During follow-up, 9 (0.49%), 14 (0.77%) and 25 (1.37%) patients developed ACS in the lowest, middle and highest tertiles, respectively. When compared with the lowest tertile of SUA, the highest tertile of SUA was associated with ACS risk in all subjects and in men and women separately (HR: 2.62, 95% CI 1.14 to 7.01, p=0.0233; 2.15, 95% CI 1.08 to 6.04, p=0.021, and 3.49, 95% CI 1.25 to 7.74, p=0.017, respectively).

Conclusions: Higher SUA levels were independently associated with an elevated risk of ACS incidence. The relationship between SUA levels and ACS in hypertensive patients was J-shaped.

Keywords: acute coronary syndrome; hypertension; uric acid.

MeSH terms

  • Acute Coronary Syndrome / epidemiology*
  • Aged
  • China / epidemiology
  • Essential Hypertension / blood
  • Essential Hypertension / epidemiology*
  • Female
  • Humans
  • Hyperuricemia / blood
  • Hyperuricemia / epidemiology*
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Proportional Hazards Models
  • Uric Acid / blood*

Substances

  • Uric Acid